ENDRA Life Sciences (NDRA) Other Non Operating Income (2016 - 2025)

ENDRA Life Sciences (NDRA) has reported Other Non Operating Income for 10 consecutive years, with -$100674.0 the latest figure, recorded in Q4 2025.

• On a quarterly basis, Other Non Operating Income fell 1960.2% year-over-year to -$100674.0 in Q4 2025; TTM through Dec 2025 was $449474.0, a 85.42% decrease from a year earlier, with the FY2025 full-year figure at -$21200.0, down 100.69% from the prior year.
• Other Non Operating Income was -$100674.0 for Q4 2025 at ENDRA Life Sciences, down from $42018.0 in the prior quarter.
• Over five years, Other Non Operating Income peaked at $3.1 million in Q3 2024 and troughed at -$300142.0 in Q4 2021.
• A 5-year average of $242426.7 and a median of $4129.5 in 2023 frame the typical range for Other Non Operating Income.
• Across the five-year window, Other Non Operating Income plunged 8481.51% in 2021 and surged 10980.93% in 2024, its largest moves.
• Over 5 years, Other Non Operating Income stood at -$300142.0 in 2021, then surged by 107.92% to $23785.0 in 2022, then soared by 3779.45% to $922726.0 in 2023, then slumped by 99.41% to $5412.0 in 2024, then slumped by 1960.2% to -$100674.0 in 2025.
• The last three Other Non Operating Income figures came in at -$100674.0 (Q4 2025), $42018.0 (Q3 2025), and $75178.0 (Q2 2025), per Business Quant data.